Browse Category

NYSE:RGLD News 8 January 2026 - 30 January 2026

Gold price near $4,500 keeps GLD in focus as CPI week begins

Gold price near $4,500 keeps GLD in focus as CPI week begins

SPDR Gold Shares closed Friday at $414.47, up 0.7%, as spot gold rose 0.5% to $4,496.09 an ounce, capping a 3.9% weekly gain. December U.S. nonfarm payrolls rose by 50,000, missing forecasts, while the dollar index climbed 0.25%. Traders see a 95% chance the Fed holds rates steady at its Jan. 27-28 meeting. Major U.S. banks begin reporting fourth-quarter earnings Tuesday, alongside December CPI data.
11 January 2026
Gold price slips ahead of U.S. jobs data as Newmont stock and GLD track bullion

Gold price slips ahead of U.S. jobs data as Newmont stock and GLD track bullion

Spot gold dropped 0.6% to $4,427.48 an ounce Thursday as funds positioned ahead of the Bloomberg Commodity Index rebalancing and the dollar strengthened. Newmont shares slipped 1.1% premarket, while SPDR Gold Shares lost 1%. HSBC projected gold could reach $5,000 in early 2026 but warned of a possible correction if Fed rate cuts stall.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop